Total Debt
$3.8M
Net Debt
-$495.8M
Edgewise Therapeutics, Inc. currently has $3.8M in total debt. Net debt is -$495.8M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
EWTX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.50 | -0.50Net Cash | 0.52 | 0.7% |
| 2025-12-31 | 0.00 | 0.53 | -0.53Net Cash | 0.55 | 0.7% |
| 2025-09-30 | 0.00 | 0.56 | -0.56Net Cash | 0.58 | 0.7% |
| 2025-06-30 | 0.00 | 0.59 | -0.59Net Cash | 0.61 | 0.7% |
| 2025-03-31 | 0.00 | 0.44 | -0.43Net Cash | 0.45 | 1.0% |
| 2024-12-31 | 0.00 | 0.47 | -0.47Net Cash | 0.49 | 1.0% |
| 2024-09-30 | 0.00 | 0.49 | -0.49Net Cash | 0.51 | 0.9% |
| 2024-06-30 | 0.00 | 0.51 | -0.51Net Cash | 0.53 | 0.9% |
| 2024-03-31 | 0.01 | 0.53 | -0.53Net Cash | 0.55 | 0.9% |
| 2023-12-31 | 0.01 | 0.32 | -0.31Net Cash | 0.34 | 1.6% |
| 2023-09-30 | 0.01 | 0.29 | -0.28Net Cash | 0.31 | 1.8% |
| 2023-06-30 | 0.01 | 0.31 | -0.30Net Cash | 0.33 | 1.7% |
| 2023-03-31 | 0.01 | 0.33 | -0.32Net Cash | 0.35 | 1.6% |
| 2022-12-31 | 0.00 | 0.35 | -0.35Net Cash | 0.37 | 1.2% |
| 2022-09-30 | 0.00 | 0.36 | -0.36Net Cash | 0.38 | 0.7% |
| 2022-06-30 | 0.00 | 0.25 | -0.25Net Cash | 0.26 | 0.7% |
| 2022-03-31 | 0.00 | 0.27 | -0.26Net Cash | 0.27 | 0.8% |
| 2021-12-31 | 0.00 | 0.28 | -0.28Net Cash | 0.29 | 0.0% |
| 2021-09-30 | 0.00 | 0.29 | -0.29Net Cash | 0.29 | 0.0% |
| 2021-06-30 | 0.00 | 0.30 | -0.30Net Cash | 0.30 | 0.0% |
| 2021-03-31 | 0.00 | 0.31 | -0.31Net Cash | 0.31 | 0.0% |
| 2020-12-31 | 0.00 | 0.13 | -0.13Net Cash | 0.13 | 0.0% |
| 2020-03-31 | 0.00 | 0.02 | -0.02Net Cash | 0.00 | — |